Company: AVCRF
Filing Date: 2025-06-16
Form Type: 20-F
Source: 0001641172-25-015266
Chunk: 83

Company: Avricore Health Inc.
Filing Date: 2025-06-16
Form: 20-F
Item: Item 19
Chunk 83
---
™ - Point of Care Business in Canada.

Revenue
from the major customer was $ 4,658,395 3,484,247 1,768,374

  15.      SUPPLEMENTAL           
           CASH FLOW INFORMATION  
 ──────────────────────────────────

There
were no non-cash transactions during the year ended December 31, 2024, 2023 and 2022.

  16.      INCOME  
           TAXES   
 ───────────────────

The
following table reconciles the expected income tax expense (recovery) at the Canadian statutory income tax rates to the amounts recognized
in the consolidated statements of operations and comprehensive loss for the year ended December 31, 2024, 2023 and 2022:

SCHEDULE OF RECONCILIATION OF EXPECTED INCOME TAX EXPENSES (RECOVERY)

 ────────────────────────────────────────────────────────────────────────────────────────────────────────────
  Loss                                                             ( 669,024      ( 701,215      ( 818,228  
  Expected                                                         ( 181,000      ( 189,000      ( 221,000  
  Change                                                           ( 245,000       ( 54,000        ( 2,000  
  Permanent                                                          148,000        192,000         91,000  
  Share                                                                    -              -        ( 5,000  
  Change                                                             278,000         51,000        137,000  
  Total                                                                    -              -                 

Avricore
Health Inc.

Notes
to the Consolidated Financial Statements

For
the years ended December 31, 2024, 2023 and 2022

(Expressed
in Canadian Dollars)

  16.      INCOME             
           TAXES (continued)  
 ──────────────────────────────

The
significant components of the Company’s deferred tax assets are as follows:

SCHEDULE OF SIGNIFICANT COMPONENTS OF DEFERRED TAX ASSET AND LIABILITIES

 ───────────────────────────────────────────────────────────────────────────────────
  Share                                  12,000           19,000           26,000  
  Property                              671,000          332,000          219,000  
  Intangible                            157,000          157,000          157,000  
  Non-capital                         5,610,000        5,664,000